摘要
目的阐明腺性膀胱炎的病变性质及积极治疗的重要性,探索经尿道电切术后加吡柔比星膀胱灌注治疗腺性膀胱炎的治疗方法及临床疗效。方法经尿道电切及术后吡柔比星膀胱灌注中长期随访,定期膀胱镜多点活检。结果63例患者,随访3~62个月,其中3例术后2年发现重度不典型增生,6例术后2年失访(原因不明),2例粘膜鳞状化,52例未见膀胱新病灶复发。结论腺性膀胱炎是膀胱粘膜增生性良性病变,是一种癌前变。经尿道电切加吡柔比星膀胱灌注治疗,可取得较好的临床效果。
Objecive To clarify the pathological changes of cystitis glandular and the importance of active treatment,and to evaluate the clinical effect of perarubicin perfusion after transurethral electroscission for cystitis glandular.Methods Long term follow-up was carried out,and regular multiplepunch biopsy by cystoscope was performed.Results Among 63 patients,52 were free of recidivation during 2 years′ follow-up while 3 had severe atypical hyperplasia and 2 had edmucosa squamatization convinced by biopsy,6 patients lost contact(reasons unknown).Conclusion Cystitis glandular is a proliferous benign lesion of bladder edmucosa and is a kind of precancerous lesion.Perfusion with perarubicin after transurethral electroscission can achieve a comparatively good clinical effect.
出处
《四川医学》
CAS
2010年第4期471-472,共2页
Sichuan Medical Journal
关键词
腺性膀胱炎
经尿道电切
吡柔比星膀胱灌注
cystitis glandular
transurethral electroscission
bladder perfusion with perarubicin